Funding

Active external funded projects:

• University of Oslo, Life Science, Convergence Environment: Fibro-PET (2022-27) 
  FIBRO-PET: Novel personalized management strategies for fibrosing diseases
   
• Oslo University Hospital strategic research area (2022-27) (Co-PI)
  FIBRO-MAN: Personalized management strategies for fibrosing diseases
  Integration of novel imaging techniques into clinical management in fibrosing diseases
   
• RADFORSK, The Norwegian Radium Hospital Research Foundation strategic research area (2023-2028) (Co-PI)
  TARACAN: Targeted Radionuclide Therapy for disseminated cancer 
   
• South-Eastern Norway Regional Health Authority/Norwegian Cancer Society (2020-2024) 
  Theranostic radiopharmaceuticals for metastatic cancer 
   
• South-Eastern Norway Regional Health Authority (2019-2024)
  A novel PET-based prediction platform for myeloma patients
   
• South-Eastern Norway Regional Health Authority and CarciNor (2018-24)
  Clinical usefulness of advanced image analysis of 18F-FDG PET/CT for in vivo characterisation of neuroendocrine carcinomas
   
• Civitan, The Alzheimer Research Fund (2018-2023)
  Amyloid imaging by 18F-Flutemetamol PET/CT and MRI – clinical value and quantitative reference levels